Skip to Content

Kelyniam Global Inc KLYG

Morningstar Rating
$0.05 −0.01 (16.67%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

KLYG is trading at a 43% discount.
Price
$0.05
Fair Value
$7.48
Uncertainty
Extreme
1-Star Price
$2.41
5-Star Price
$8.57
Economic Moat
Hrfh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KLYG is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.06
Day Range
$0.050.05
52-Week Range
$0.050.10
Bid/Ask
$0.05 / $0.06
Market Cap
$976,130.00
Volume/Avg
667 / 26,455

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Kelyniam Global Inc engaged in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees

Valuation

Metric
KLYG
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
KLYG
Quick Ratio
0.08
Current Ratio
0.08
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
KLYG
Return on Assets (Normalized)
−345.06%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−7,604.84%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesSnpjzkksNshrm$185.5 Bil
SYK
Stryker CorpKvplszftbHxgvc$128.2 Bil
MDT
Medtronic PLCVwrkjhzQsmxp$106.7 Bil
BSX
Boston Scientific CorpZbdgcqhytWmvlppp$99.0 Bil
DXCM
DexCom IncCswrpzwhnJbbw$53.1 Bil
EW
Edwards Lifesciences CorpLqfktzhmlsLcjhlg$52.8 Bil
ZBH
Zimmer Biomet Holdings IncZxysprfbnDrry$24.9 Bil
ALGN
Align Technology IncScwfjsbLtftxrk$23.5 Bil
PHG
Koninklijke Philips NV ADRBtzxmknhWnqtt$18.9 Bil
PODD
Insulet CorpFxcfdcwcHvvgtn$11.7 Bil

Sponsor Center